Cargando…

Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia

INTRODUCTION: Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children. The factors predisposing to ALL remain mostly unknown. Natural killer (NK) cells are a component of innate immunity. Their role is to eliminate cells that were infected with viruses or underwent a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Kołtan, Sylwia, Kołtan, Andrzej, Soszyńska, Krystyna, Matiakowska, Karolina, Morgut-Klimkowska, Małgorzata, Grześk, Elżbieta, Grześk, Grzegorz, Dąbrowska, Anna, Urbańczyk, Anna, Konieczek, Joanna, Styczyński, Jan, Haus, Olga, Wysocki, Mariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568030/
https://www.ncbi.nlm.nih.gov/pubmed/34764789
http://dx.doi.org/10.5114/ceji.2021.108178
_version_ 1784594347282399232
author Kołtan, Sylwia
Kołtan, Andrzej
Soszyńska, Krystyna
Matiakowska, Karolina
Morgut-Klimkowska, Małgorzata
Grześk, Elżbieta
Grześk, Grzegorz
Dąbrowska, Anna
Urbańczyk, Anna
Konieczek, Joanna
Styczyński, Jan
Haus, Olga
Wysocki, Mariusz
author_facet Kołtan, Sylwia
Kołtan, Andrzej
Soszyńska, Krystyna
Matiakowska, Karolina
Morgut-Klimkowska, Małgorzata
Grześk, Elżbieta
Grześk, Grzegorz
Dąbrowska, Anna
Urbańczyk, Anna
Konieczek, Joanna
Styczyński, Jan
Haus, Olga
Wysocki, Mariusz
author_sort Kołtan, Sylwia
collection PubMed
description INTRODUCTION: Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children. The factors predisposing to ALL remain mostly unknown. Natural killer (NK) cells are a component of innate immunity. Their role is to eliminate cells that were infected with viruses or underwent a neoplastic transformation. The activity of NK cells is regulated by their activating and inhibitory receptors, inter alia killer-cell immunoglobulin-like receptors (KIRs). The available data about a link between the incidence of ALL and KIR genotype are highly inconclusive, and further research is needed to explain whether such a relationship truly exists. The aim of this study was to analyze KIR genotype and haplotype combinations in children treated for ALL. MATERIAL AND METHODS: The study included 49 children diagnosed with ALL at 1.2-19.8 years of age. The control group was composed of 43 healthy subjects aged between 1.2 and 21.9 years. DNA was isolated using QIAamp DNA Mini kits. KIR genotypes were identified by a polymerase chain reaction (PCR) with sequence-specific primers (SSPs). The analysis also included KIR haplotype combinations: AA, AB and BB. RESULTS: Patients with ALL and controls did not differ significantly in the frequencies of individual KIR genes and haplotypes. However, the overall frequency of all 6 activating KIR genes in patients with ALL was significantly higher than in the controls (24.5% vs. 4.7%, p = 0.019). CONCLUSIONS: The findings presented here imply that individual KIR genes do not play a significant role in the pathogenesis of ALL. Nevertheless, a higher number of activating KIR genes may constitute a risk factor for this malignancy.
format Online
Article
Text
id pubmed-8568030
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-85680302021-11-10 Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia Kołtan, Sylwia Kołtan, Andrzej Soszyńska, Krystyna Matiakowska, Karolina Morgut-Klimkowska, Małgorzata Grześk, Elżbieta Grześk, Grzegorz Dąbrowska, Anna Urbańczyk, Anna Konieczek, Joanna Styczyński, Jan Haus, Olga Wysocki, Mariusz Cent Eur J Immunol Clinical Immunology INTRODUCTION: Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children. The factors predisposing to ALL remain mostly unknown. Natural killer (NK) cells are a component of innate immunity. Their role is to eliminate cells that were infected with viruses or underwent a neoplastic transformation. The activity of NK cells is regulated by their activating and inhibitory receptors, inter alia killer-cell immunoglobulin-like receptors (KIRs). The available data about a link between the incidence of ALL and KIR genotype are highly inconclusive, and further research is needed to explain whether such a relationship truly exists. The aim of this study was to analyze KIR genotype and haplotype combinations in children treated for ALL. MATERIAL AND METHODS: The study included 49 children diagnosed with ALL at 1.2-19.8 years of age. The control group was composed of 43 healthy subjects aged between 1.2 and 21.9 years. DNA was isolated using QIAamp DNA Mini kits. KIR genotypes were identified by a polymerase chain reaction (PCR) with sequence-specific primers (SSPs). The analysis also included KIR haplotype combinations: AA, AB and BB. RESULTS: Patients with ALL and controls did not differ significantly in the frequencies of individual KIR genes and haplotypes. However, the overall frequency of all 6 activating KIR genes in patients with ALL was significantly higher than in the controls (24.5% vs. 4.7%, p = 0.019). CONCLUSIONS: The findings presented here imply that individual KIR genes do not play a significant role in the pathogenesis of ALL. Nevertheless, a higher number of activating KIR genes may constitute a risk factor for this malignancy. Termedia Publishing House 2021-08-07 2021 /pmc/articles/PMC8568030/ /pubmed/34764789 http://dx.doi.org/10.5114/ceji.2021.108178 Text en Copyright © 2021 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Clinical Immunology
Kołtan, Sylwia
Kołtan, Andrzej
Soszyńska, Krystyna
Matiakowska, Karolina
Morgut-Klimkowska, Małgorzata
Grześk, Elżbieta
Grześk, Grzegorz
Dąbrowska, Anna
Urbańczyk, Anna
Konieczek, Joanna
Styczyński, Jan
Haus, Olga
Wysocki, Mariusz
Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia
title Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia
title_full Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia
title_fullStr Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia
title_full_unstemmed Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia
title_short Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia
title_sort killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia
topic Clinical Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568030/
https://www.ncbi.nlm.nih.gov/pubmed/34764789
http://dx.doi.org/10.5114/ceji.2021.108178
work_keys_str_mv AT kołtansylwia killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia
AT kołtanandrzej killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia
AT soszynskakrystyna killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia
AT matiakowskakarolina killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia
AT morgutklimkowskamałgorzata killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia
AT grzeskelzbieta killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia
AT grzeskgrzegorz killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia
AT dabrowskaanna killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia
AT urbanczykanna killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia
AT konieczekjoanna killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia
AT styczynskijan killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia
AT hausolga killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia
AT wysockimariusz killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia